22nd Century Group Inc., based in Clarence, NY, is a leading agricultural biotechnology company specializing in plant science to enhance health and wellness. Utilizing innovative plant breeding technologies, including genetic engineering and molecular breeding, the company focuses on developing reduced nicotine content tobacco plants and cigarettes to aid in harm reduction for smokers.
With the first and only FDA authorization for a reduced nicotine combustible cigarette, 22nd Century Group is dedicated to creating proprietary plants with unique alkaloid profiles to address pressing health issues. Their mission is to empower plants for a healthier future by providing solutions that aim to reduce the harm caused by smoking and improve public health.
Generated from the website